Radiotherapy combined with gefitinib for patients with locally advanced non-small cell lung cancer who are unfit for surgery or concurrent chemoradiotherapy: a phase II clinical trial

BACKGROUND: The objectives of this study were to determine the objective effective response rate, survival, and safety of radiotherapy combined with gefitinib in patients with locally advanced non-small cell lung cancer (NSCLC) who were unfit for surgery or concurrent chemoradiotherapy. METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Zhixue, Yang, Xu, Wang, Wenqing, Deng, Lei, Zhang, Tao, Bi, Nan, Wang, Xiaozhen, Chen, Dongfu, Zhou, Zongmei, Wang, Luhua, Liang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305585/
https://www.ncbi.nlm.nih.gov/pubmed/32563259
http://dx.doi.org/10.1186/s13014-020-01596-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305585/
https://www.ncbi.nlm.nih.gov/pubmed/32563259
http://dx.doi.org/10.1186/s13014-020-01596-2

Ejemplares similares